2015
DOI: 10.1016/j.clay.2014.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of orally administered montmorillonite for acute iron poisoning detoxification in rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…Many researcher have been studied to develop alternative chelators such as covalently attached DFO to dextran and hydroxyethyl starch (HES), degradable PEG based copolymers, hydroxamic acid group containing hydrogels, dendrimeric iron chelators and polymer based chelators for treatment acute iron poisoning. Therefore, several techniques and chelation therapies have been investigated [15][16][17][18][19][20]. Among them, polymeric chelating agents with their superior feature because of non-toxicity, high affinity and specifty to iron ions, biocompatibility, forming fast and insoluble complex, preventing the absorption of Fe 3+ ion in GI tract, promoting the removal of iron and orally active is the most promising adsorbent [21][22][23][24][25][26][27][28][29].…”
Section: Introductionmentioning
confidence: 99%
“…Many researcher have been studied to develop alternative chelators such as covalently attached DFO to dextran and hydroxyethyl starch (HES), degradable PEG based copolymers, hydroxamic acid group containing hydrogels, dendrimeric iron chelators and polymer based chelators for treatment acute iron poisoning. Therefore, several techniques and chelation therapies have been investigated [15][16][17][18][19][20]. Among them, polymeric chelating agents with their superior feature because of non-toxicity, high affinity and specifty to iron ions, biocompatibility, forming fast and insoluble complex, preventing the absorption of Fe 3+ ion in GI tract, promoting the removal of iron and orally active is the most promising adsorbent [21][22][23][24][25][26][27][28][29].…”
Section: Introductionmentioning
confidence: 99%
“…Deferoxamine mesylate (DFA) is a commercial medicine used to treat thalassemia or iron poisoning . However, Hou et al reported that deferoxamine could be helpful in the wound healing process of diabetic rats.…”
Section: Introductionmentioning
confidence: 99%